Vivere, a leading fertility management and equity partner, announced today the beginning of construction on Kentucky Fertility Institute (KFI), the company’s first fertility practice and in vitro fertilization (IVF) laboratory in the state.
“Our company is on a very positive trajectory with new business on the horizon in everything from existing large practices to de novo businesses such as Louisville. As part of our overarching plan, we identified metropolitan areas in the country that are underserved for those who would benefit from infertility treatment. Louisville is a strategic market for us and we found great physician partners that are forward-thinking and patient focused,” says Vivere President and Chief Executive Officer Debbie James.
Louisville-based reproductive endocrinologist and infertility specialist Robert Hunter, MD, who will serve as the medical director of Kentucky Fertility Institute stated, “We are thrilled to be partnering with Vivere. They have an impressive track record of growing businesses and providing high quality clinical expertise to support the physician’s vision. We look forward to a long, successful relationship.”
Kentucky Fertility Institute will be a multi-provider center offering comprehensive reproductive healthcare services including in vitro fertilization, elective egg freezing, donors and surrogates, and fertility preservation for oncology patients. On course to open later this year, KFI will be located in an upscale mixed-use development in northeast Louisville. The 6,600 square foot facility features five examination rooms, two procedure rooms, and a state-of-the-art IVF laboratory.
Vivere has established a noteworthy history of developing fertility practices in a highly competitive and dynamic market segment. In just the last three years, Vivere has more than tripled in revenue. Vivere’s impressive growth – with annual revenues now more than $100 million – led the Nashville Business Journal to name Vivere the Fastest Growing Private Company in Middle Tennessee last year.